Vanda Pharmaceuticals Inc.·4

Mar 2, 5:37 PM ET

Reverberi Gian Piero 4

4 · Vanda Pharmaceuticals Inc. · Filed Mar 2, 2018

Insider Transaction Report

Form 4
Period: 2018-02-28
Reverberi Gian Piero
SVP, General Manager Europe
Transactions
  • Award

    Common Stock

    2018-02-28+30,000140,000 total
  • Award

    Employee Stock Option (Right to Buy)

    2018-02-28+70,00070,000 total
    Exercise: $18.85Exp: 2028-02-27Common Stock (70,000 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU vests in four (4) equal annual installments beginning February 28, 2019, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
  • [F2]The option vests in forty-eight (48) equal monthly installments beginning on February 28, 2018, provided the Reporting Person remains continuously employed by the Issuer through each vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION